ftInvstr

PANACEABIO · Healthcare ₹358.1 +0.6% Mkt Cap ₹2194 Cr

PANACEABIO

Healthcare Biotechnology

★ Watchlist ⧉ Add to bucket

₹358.1

+0.6% today · 30d +2.99%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for PANACEABIO. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-06-30

REVENUE

₹200 Cr

+19.72% YoY

NET PROFIT

₹2 Cr

-44.44% YoY

OPM

4.86%

+2.26pp YoY

EPS

₹0.38

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

PANACEABIO—-5.0

BIOCON175.486.88

ANTHEM87.931.1

ONESOURCE—4.57

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance UNDERPERFORMER 20

Valuation — —

Growth STEADY 57

Profitability LOW 18

Technicals WEAK 47

Risk LOW 80

Key Stats

P/B

2.75

52W HIGH

₹647.0

OFF HIGH

-44.65%

DIV YIELD

0.0%

MKT CAP

₹2194 Cr

◉ Active Signals

MACDNeutral5.3647

RSI(14)Neutral54.54

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold PANACEABIO and at what entry.